151 related articles for article (PubMed ID: 38693690)
1. Examining labelling guidelines for AI-based software as a medical device: A review and analysis of dermatology mobile applications in Australia.
Oloruntoba A; Ingvar Å; Sashindranath M; Anthony O; Abbott L; Guitera P; Caccetta T; Janda M; Soyer HP; Mar V
Australas J Dermatol; 2024 May; ():. PubMed ID: 38693690
[TBL] [Abstract][Full Text] [Related]
2. Minimum labelling requirements for dermatology artificial intelligence-based Software as Medical Device (SaMD): A consensus statement.
Ingvar Å; Oloruntoba A; Sashindranath M; Miller R; Soyer HP; Guitera P; Caccetta T; Shumack S; Abbott L; Arnold C; Lawn C; Button-Sloan A; Janda M; Mar V
Australas J Dermatol; 2024 May; 65(3):e21-e29. PubMed ID: 38419186
[TBL] [Abstract][Full Text] [Related]
3. Methodology for Conducting Post-Marketing Surveillance of Software as a Medical Device Based on Artificial Intelligence Technologies.
Zinchenko VV; Arzamasov KM; Chetverikov SF; Maltsev AV; Novik VP; Akhmad ES; Sharova DE; Andreychenko AE; Vladzymyrskyy AV; Morozov SP
Sovrem Tekhnologii Med; 2022; 14(5):15-23. PubMed ID: 37181834
[TBL] [Abstract][Full Text] [Related]
4. Changes in software as a medical device based on artificial intelligence technologies.
Zinchenko V; Chetverikov S; Akhmad E; Arzamasov K; Vladzymyrskyy A; Andreychenko A; Morozov S
Int J Comput Assist Radiol Surg; 2022 Oct; 17(10):1969-1977. PubMed ID: 35691995
[TBL] [Abstract][Full Text] [Related]
5. Innovation Process and Industrial System of US Food and Drug Administration-Approved Software as a Medical Device: Review and Content Analysis.
Yu J; Zhang J; Sengoku S
J Med Internet Res; 2023 Nov; 25():e47505. PubMed ID: 37999948
[TBL] [Abstract][Full Text] [Related]
6. Technology-Enabled, Evidence-Driven, and Patient-Centered: The Way Forward for Regulating Software as a Medical Device.
Carolan JE; McGonigle J; Dennis A; Lorgelly P; Banerjee A
JMIR Med Inform; 2022 Jan; 10(1):e34038. PubMed ID: 35084352
[TBL] [Abstract][Full Text] [Related]
7. Understanding the factors influencing acceptability of AI in medical imaging domains among healthcare professionals: A scoping review.
Hua D; Petrina N; Young N; Cho JG; Poon SK
Artif Intell Med; 2024 Jan; 147():102698. PubMed ID: 38184343
[TBL] [Abstract][Full Text] [Related]
8. Artificial intelligence in medicine - dermatology compared to other medical specialties in FDA-cleared software as medical device.
Vidal NY; Sidey K; Kim YH; Vidal DE
Dermatol Online J; 2023 Apr; 29(2):. PubMed ID: 37220282
[TBL] [Abstract][Full Text] [Related]
9. Collection and Analysis of Adherence Information for Software as a Medical Device Clinical Trials: Systematic Review.
Grayek E; Krishnamurti T; Hu L; Babich O; Warren K; Fischhoff B
JMIR Mhealth Uhealth; 2023 Nov; 11():e46237. PubMed ID: 37966871
[TBL] [Abstract][Full Text] [Related]
10. Position statement of the EADV Artificial Intelligence (AI) Task Force on AI-assisted smartphone apps and web-based services for skin disease.
Sangers TE; Kittler H; Blum A; Braun RP; Barata C; Cartocci A; Combalia M; Esdaile B; Guitera P; Haenssle HA; Kvorning N; Lallas A; Navarrete-Dechent C; Navarini AA; Podlipnik S; Rotemberg V; Soyer HP; Tognetti L; Tschandl P; Malvehy J;
J Eur Acad Dermatol Venereol; 2024 Jan; 38(1):22-30. PubMed ID: 37766502
[TBL] [Abstract][Full Text] [Related]
11. Tracking the Presence of Software as a Medical Device in US Food and Drug Administration Databases: Retrospective Data Analysis.
Ceross A; Bergmann J
JMIR Biomed Eng; 2021 Nov; 6(4):e20652. PubMed ID: 38907384
[TBL] [Abstract][Full Text] [Related]
12. Comparison of humans versus mobile phone-powered artificial intelligence for the diagnosis and management of pigmented skin cancer in secondary care: a multicentre, prospective, diagnostic, clinical trial.
Menzies SW; Sinz C; Menzies M; Lo SN; Yolland W; Lingohr J; Razmara M; Tschandl P; Guitera P; Scolyer RA; Boltz F; Borik-Heil L; Herbert Chan H; Chromy D; Coker DJ; Collgros H; Eghtedari M; Corral Forteza M; Forward E; Gallo B; Geisler S; Gibson M; Hampel A; Ho G; Junez L; Kienzl P; Martin A; Moloney FJ; Regio Pereira A; Ressler JM; Richter S; Silic K; Silly T; Skoll M; Tittes J; Weber P; Weninger W; Weiss D; Woo-Sampson P; Zilberg C; Kittler H
Lancet Digit Health; 2023 Oct; 5(10):e679-e691. PubMed ID: 37775188
[TBL] [Abstract][Full Text] [Related]
13. Conceptualising Artificial Intelligence as a Digital Healthcare Innovation: An Introductory Review.
Arora A
Med Devices (Auckl); 2020; 13():223-230. PubMed ID: 32904333
[TBL] [Abstract][Full Text] [Related]
14. The need for a system view to regulate artificial intelligence/machine learning-based software as medical device.
Gerke S; Babic B; Evgeniou T; Cohen IG
NPJ Digit Med; 2020; 3():53. PubMed ID: 32285013
[TBL] [Abstract][Full Text] [Related]
15. Artificial intelligence (AI) impacting diagnosis of glaucoma and understanding the regulatory aspects of AI-based software as medical device.
Prabhakar B; Singh RK; Yadav KS
Comput Med Imaging Graph; 2021 Jan; 87():101818. PubMed ID: 33307283
[TBL] [Abstract][Full Text] [Related]
16. Clinical Simulation in the Regulation of Software as a Medical Device: An eDelphi Study.
O'Driscoll F; O'Brien N; Guo C; Prime M; Darzi A; Ghafur S
JMIR Form Res; 2024 Jun; 8():e56241. PubMed ID: 38917454
[TBL] [Abstract][Full Text] [Related]
17. Deep Learning in Dermatology: A Systematic Review of Current Approaches, Outcomes, and Limitations.
Jeong HK; Park C; Henao R; Kheterpal M
JID Innov; 2023 Jan; 3(1):100150. PubMed ID: 36655135
[TBL] [Abstract][Full Text] [Related]
18. Global Regulatory Frameworks for the Use of Artificial Intelligence (AI) in the Healthcare Services Sector.
Palaniappan K; Lin EYT; Vogel S
Healthcare (Basel); 2024 Feb; 12(5):. PubMed ID: 38470673
[TBL] [Abstract][Full Text] [Related]
19. Artificial Intelligence and Machine Learning Applied at the Point of Care.
Angehrn Z; Haldna L; Zandvliet AS; Gil Berglund E; Zeeuw J; Amzal B; Cheung SYA; Polasek TM; Pfister M; Kerbusch T; Heckman NM
Front Pharmacol; 2020; 11():759. PubMed ID: 32625083
[TBL] [Abstract][Full Text] [Related]
20. The current status of breakthrough devices designation in the United States and innovative medical devices designation in Korea for digital health software.
Woo JH; Kim EC; Kim SM
Expert Rev Med Devices; 2022 Mar; 19(3):213-228. PubMed ID: 35255755
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
